Ind-Swift Laboratories has collaborated with The Council of Scientific and Industrial Research (CSIR) - Institute of Microbial Technology (IMTECH), a premier microbial institute under the aegis of the Ministry of Science and Technology, Government of India, for development of Biotransformation Process (Enzymatic Process) for its products.
The agreement between Ind-Swift and CSIR-IMTECH will enable scientists from both the organizations to work closely on development of Biotransformation process (Enzymatic Process) for its products. For this project, scientists at IMTECH will utilize their expertise and scientific know how in microbiology while Ind-Swift team will provide its expertise in process chemistry & pharmaceutical drug development’s analytical resources.
Ind-Swift Laboratories is global manufacturer of Active Pharmaceutical Ingredients (API), Intermediates and formulations (through group collaboration).
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1837.15 |
| Dr. Reddys Lab | 1271.55 |
| Cipla | 1353.85 |
| Zydus Lifesciences | 1070.90 |
| Lupin | 2351.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: